These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

577 related items for PubMed ID: 20501937

  • 1. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.
    Razani B, Zarnegar B, Ytterberg AJ, Shiba T, Dempsey PW, Ware CF, Loo JA, Cheng G.
    Sci Signal; 2010 May 25; 3(123):ra41. PubMed ID: 20501937
    [Abstract] [Full Text] [Related]

  • 2. Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.
    Matsushima A, Kaisho T, Rennert PD, Nakano H, Kurosawa K, Uchida D, Takeda K, Akira S, Matsumoto M.
    J Exp Med; 2001 Mar 05; 193(5):631-6. PubMed ID: 11238593
    [Abstract] [Full Text] [Related]

  • 3. Maximal adamantyl-substituted retinoid-related molecule-induced apoptosis requires NF-κB noncanonical and canonical pathway activation.
    Farhana L, Dawson MI, Murshed F, Fontana JA.
    Cell Death Differ; 2011 Jan 05; 18(1):164-73. PubMed ID: 20671747
    [Abstract] [Full Text] [Related]

  • 4. Controlling the fate of NIK: a central stage in noncanonical NF-kappaB signaling.
    Sun SC.
    Sci Signal; 2010 May 25; 3(123):pe18. PubMed ID: 20501935
    [Abstract] [Full Text] [Related]

  • 5. Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways.
    Pham LV, Fu L, Tamayo AT, Bueso-Ramos C, Drakos E, Vega F, Medeiros LJ, Ford RJ.
    Blood; 2011 Jan 06; 117(1):200-10. PubMed ID: 20889926
    [Abstract] [Full Text] [Related]

  • 6. Negative feedback regulation of NF-κB-inducing kinase is proteasome-dependent but does not require cellular inhibitors of apoptosis.
    Gray CM, McCorkell KA, Chunduru SK, McKinlay MA, May MJ.
    Biochem Biophys Res Commun; 2014 Jul 18; 450(1):341-6. PubMed ID: 24942881
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Noncanonical NF-κB signaling is limited by classical NF-κB activity.
    Gray CM, Remouchamps C, McCorkell KA, Solt LA, Dejardin E, Orange JS, May MJ.
    Sci Signal; 2014 Feb 04; 7(311):ra13. PubMed ID: 24497610
    [Abstract] [Full Text] [Related]

  • 9. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling.
    Kanno Y, Sakurai D, Hase H, Kojima H, Kobata T.
    J Recept Signal Transduct Res; 2010 Apr 04; 30(2):121-32. PubMed ID: 20184394
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.
    Luftig M, Yasui T, Soni V, Kang MS, Jacobson N, Cahir-McFarland E, Seed B, Kieff E.
    Proc Natl Acad Sci U S A; 2004 Jan 06; 101(1):141-6. PubMed ID: 14691250
    [Abstract] [Full Text] [Related]

  • 11. NIK-IKK complex interaction controls NF-κB-dependent inflammatory activation of endothelium in response to LTβR ligation.
    Kucharzewska P, Maracle CX, Jeucken KCM, van Hamburg JP, Israelsson E, Furber M, Tas SW, Olsson HK.
    J Cell Sci; 2019 Apr 03; 132(7):. PubMed ID: 30837284
    [Abstract] [Full Text] [Related]

  • 12. The NF-kappa B activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536.
    Jiang X, Takahashi N, Matsui N, Tetsuka T, Okamoto T.
    J Biol Chem; 2003 Jan 10; 278(2):919-26. PubMed ID: 12419817
    [Abstract] [Full Text] [Related]

  • 13. Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kappaB.
    Grotterød I, Maelandsmo GM, Boye K.
    BMC Cancer; 2010 May 28; 10():241. PubMed ID: 20507646
    [Abstract] [Full Text] [Related]

  • 14. CDK12-mediated transcriptional regulation of noncanonical NF-κB components is essential for signaling.
    Henry KL, Kellner D, Bajrami B, Anderson JE, Beyna M, Bhisetti G, Cameron T, Capacci AG, Bertolotti-Ciarlet A, Feng J, Gao B, Hopkins B, Jenkins T, Li K, May-Dracka T, Murugan P, Wei R, Zeng W, Allaire N, Buckler A, Loh C, Juhasz P, Lucas B, Ennis KA, Vollman E, Cahir-McFarland E, Hett EC, Ols ML.
    Sci Signal; 2018 Jul 31; 11(541):. PubMed ID: 30065029
    [Abstract] [Full Text] [Related]

  • 15. Non-canonical NF-κB signaling pathway.
    Sun SC.
    Cell Res; 2011 Jan 31; 21(1):71-85. PubMed ID: 21173796
    [Abstract] [Full Text] [Related]

  • 16. Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.
    Yang CH, Murti A, Pfeffer LM.
    J Biol Chem; 2005 Sep 09; 280(36):31530-6. PubMed ID: 16009713
    [Abstract] [Full Text] [Related]

  • 17. Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways.
    Müller JR, Siebenlist U.
    J Biol Chem; 2003 Apr 04; 278(14):12006-12. PubMed ID: 12556537
    [Abstract] [Full Text] [Related]

  • 18. Effects of the NIK aly mutation on NF-kappaB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40.
    Luftig MA, Cahir-McFarland E, Mosialos G, Kieff E.
    J Biol Chem; 2001 May 04; 276(18):14602-6. PubMed ID: 11278268
    [Abstract] [Full Text] [Related]

  • 19. B-cell CLL/lymphoma 10 (BCL10) is required for NF-kappaB production by both canonical and noncanonical pathways and for NF-kappaB-inducing kinase (NIK) phosphorylation.
    Bhattacharyya S, Borthakur A, Tyagi S, Gill R, Chen ML, Dudeja PK, Tobacman JK.
    J Biol Chem; 2010 Jan 01; 285(1):522-30. PubMed ID: 19897484
    [Abstract] [Full Text] [Related]

  • 20. A TNF-p100 pathway subverts noncanonical NF-κB signaling in inflamed secondary lymphoid organs.
    Mukherjee T, Chatterjee B, Dhar A, Bais SS, Chawla M, Roy P, George A, Bal V, Rath S, Basak S.
    EMBO J; 2017 Dec 01; 36(23):3501-3516. PubMed ID: 29061763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.